Faster chemistry with Syrris reactor

- Last updated on GMT

Related tags: Chemical reaction

UK-based chemistry specialist Syrris has developed a new
microreactor that, it claims, can speed up the optimisation of
process reactions used in the drug industry.

The AFRICA (Automated Flow Reaction Incubation and Control Apparatus) microreactor was developed in partnership with the world's number two pharmaceutical company GlaxoSmithKline. GSK collaborated with Syrris on a new micro-scale flow technology used in the product.

AFRICA combines reaction optimisation and synthesis in one system, which reduces the time it takes to create new compounds. Aside from its obvious applications in process development and reaction optimisation, the unit is also expected to be used in drug discovery.

Using the system, reactions occur under laminar flow conditions, to improve control and reproducibility, and the system allows multiple reaction conditions such as time, temperature and stoichiometry, to be run and analysed automatically, according to Syrris​.

Analysis predicts the next set of experiments allowing rapid iterative optimisation to be performed. The system is already in use at GSK's research facilities at Harlow, UK.

Related topics: Processing, QA/QC, Processing equipment

Related news

Show more

Related products

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers